Skip to main content
S 1097 119th Congress Senate Commerce Drug safety, medical device, and laboratory regulation Food and Drug Administration (FDA) Intellectual property Intergovernmental relations

Interagency Patent Coordination and Improvement Act of 2025

Introduced: March 24, 2025 Introduced by: Durbin, Richard J. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 10, 2025
Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Apr 10, 2025
Committee on the Judiciary. Reported by Senator Grassley with amendments. Without written report.
Apr 3, 2025
Committee on the Judiciary. Ordered to be reported with amendments favorably.
Mar 24, 2025
Read twice and referred to the Committee on the Judiciary. (text: CR S1804-1805)
Mar 24, 2025
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Interagency Patent Coordination and Improvement Act of 2025

This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.

The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.

What's happening now April 10, 2025

Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.

 Hearings & markups 1
 Related & companion bills 1
  • HR 4570 Related bill Interagency Patent Coordination and Improvement Act of 2025
 Bill text 2 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 105

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

See all 105 filings →
 Cosponsors 4
All 4 Democratic 2 Republican 2
D
Coons, Christopher A.
Delaware · Mar 24, 2025
 R
Grassley, Chuck
Iowa · Mar 24, 2025
 R
Tillis, Thomas
North Carolina · Mar 24, 2025
 D
Welch, Peter
Vermont · Mar 24, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). S. 1097: Interagency Patent Coordination and Improvement Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-S-1097/
MLA
"S. 1097: Interagency Patent Coordination and Improvement Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-S-1097/.
Bluebook (legal)
S. 1097, 119th Cong. (2026), https://openamerica.io/bill/119-S-1097/.
Markdown link
[S. 1097: Interagency Patent Coordination and Improvement Act of 2025](https://openamerica.io/bill/119-S-1097/)
Report a problem